Investigation of Urination Disorder in Parkinson′s disease

Background: Urination disorders are common in Parkinson′s disease (PD) and respond poorly to medication. This study aimed to analyze the risk factors for urination disorders in PD. Methods: Ninety-one patients with PD (aged 34-83 years old) were recruited. Patients were assessed with the Unified PD...

Full description

Bibliographic Details
Main Authors: Li-Mei Zhang, Xu-Ping Zhang
Format: Article
Language:English
Published: Wolters Kluwer 2015-01-01
Series:Chinese Medical Journal
Subjects:
Online Access:http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=21;spage=2906;epage=2912;aulast=Zhang
id doaj-a67579ca78444454a6331ea962a08a9d
record_format Article
spelling doaj-a67579ca78444454a6331ea962a08a9d2020-11-24T21:32:00ZengWolters KluwerChinese Medical Journal0366-69992015-01-01128212906291210.4103/0366-6999.168049Investigation of Urination Disorder in Parkinson′s diseaseLi-Mei ZhangXu-Ping ZhangBackground: Urination disorders are common in Parkinson′s disease (PD) and respond poorly to medication. This study aimed to analyze the risk factors for urination disorders in PD. Methods: Ninety-one patients with PD (aged 34-83 years old) were recruited. Patients were assessed with the Unified PD Rating Scale (UPDRS), Hoehn and Yahr stage, Pittsburgh Sleep Quality Index (PSQI), Hamilton Depression Rating Scale (HAMD), and Hamilton Anxiety Scale (HAMA). Micturition number was recorded, and Type B ultrasound was used to evaluate residual urine. Statistics was performed using binary logistic regression, bivariate correlations, and Chi-square and t-tests. Results: Of 91 patients, urinary dysfunction occurred in 55.0%. Among these, 49.5% suffered with nocturia, 47.3% with pollakiuria. Nocturia number had a positive linear relationship with HAMA score (odds ratio [OR] = 0.340, P = 0.001), HAMD score (OR = 0.323, P = 0.002), duration of L-dopa medication (OR = 0.328, P = 0.001), dose of L-dopa (OR = 0.273, P = 0.009), UPDRS-II (OR = 0.402, P = 0.000), UPDRS-III score (OR = 0.291, P = 0.005), and PSQI score (OR = 0.249, P = 0.017). Micturition number over 24 h was positively associated with HAMA (OR = 0.303, P = 0.004) and UPDRS-II scores (OR = 0.306, P = 0.003). Of patients with residual urine, 79.3% had a volume of residual urine <50 ml. Residual urine was present in 44.4% of the patients with nocturia, 46.5% of the patients with pollakiuria, and 80.0% of the patients with dysuria. More men than women had residual urine (35.2% male vs. 13.3% female; P = 0.002). Conclusions: Nocturia and pollakiuria were common micturition symptoms in our participants with PD. Nocturia was associated with depression, anxiety, sleep problems, and severity of PD. Pollakiuria was associated with anxiety and severity of PD. Male patients were more prone to residual urine and pollakiuria.http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=21;spage=2906;epage=2912;aulast=ZhangNocturia; Parkinson′s Disease; Risk Factors; Urine Disorders
collection DOAJ
language English
format Article
sources DOAJ
author Li-Mei Zhang
Xu-Ping Zhang
spellingShingle Li-Mei Zhang
Xu-Ping Zhang
Investigation of Urination Disorder in Parkinson′s disease
Chinese Medical Journal
Nocturia; Parkinson′s Disease; Risk Factors; Urine Disorders
author_facet Li-Mei Zhang
Xu-Ping Zhang
author_sort Li-Mei Zhang
title Investigation of Urination Disorder in Parkinson′s disease
title_short Investigation of Urination Disorder in Parkinson′s disease
title_full Investigation of Urination Disorder in Parkinson′s disease
title_fullStr Investigation of Urination Disorder in Parkinson′s disease
title_full_unstemmed Investigation of Urination Disorder in Parkinson′s disease
title_sort investigation of urination disorder in parkinson′s disease
publisher Wolters Kluwer
series Chinese Medical Journal
issn 0366-6999
publishDate 2015-01-01
description Background: Urination disorders are common in Parkinson′s disease (PD) and respond poorly to medication. This study aimed to analyze the risk factors for urination disorders in PD. Methods: Ninety-one patients with PD (aged 34-83 years old) were recruited. Patients were assessed with the Unified PD Rating Scale (UPDRS), Hoehn and Yahr stage, Pittsburgh Sleep Quality Index (PSQI), Hamilton Depression Rating Scale (HAMD), and Hamilton Anxiety Scale (HAMA). Micturition number was recorded, and Type B ultrasound was used to evaluate residual urine. Statistics was performed using binary logistic regression, bivariate correlations, and Chi-square and t-tests. Results: Of 91 patients, urinary dysfunction occurred in 55.0%. Among these, 49.5% suffered with nocturia, 47.3% with pollakiuria. Nocturia number had a positive linear relationship with HAMA score (odds ratio [OR] = 0.340, P = 0.001), HAMD score (OR = 0.323, P = 0.002), duration of L-dopa medication (OR = 0.328, P = 0.001), dose of L-dopa (OR = 0.273, P = 0.009), UPDRS-II (OR = 0.402, P = 0.000), UPDRS-III score (OR = 0.291, P = 0.005), and PSQI score (OR = 0.249, P = 0.017). Micturition number over 24 h was positively associated with HAMA (OR = 0.303, P = 0.004) and UPDRS-II scores (OR = 0.306, P = 0.003). Of patients with residual urine, 79.3% had a volume of residual urine <50 ml. Residual urine was present in 44.4% of the patients with nocturia, 46.5% of the patients with pollakiuria, and 80.0% of the patients with dysuria. More men than women had residual urine (35.2% male vs. 13.3% female; P = 0.002). Conclusions: Nocturia and pollakiuria were common micturition symptoms in our participants with PD. Nocturia was associated with depression, anxiety, sleep problems, and severity of PD. Pollakiuria was associated with anxiety and severity of PD. Male patients were more prone to residual urine and pollakiuria.
topic Nocturia; Parkinson′s Disease; Risk Factors; Urine Disorders
url http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=21;spage=2906;epage=2912;aulast=Zhang
work_keys_str_mv AT limeizhang investigationofurinationdisorderinparkinsonsdisease
AT xupingzhang investigationofurinationdisorderinparkinsonsdisease
_version_ 1725958931797245952